|
Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses
|
journal
|
March 2010 |
|
The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker
|
journal
|
May 2013 |
|
The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design
|
journal
|
June 2016 |
|
Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism
|
journal
|
February 2019 |
|
Mapping and Role of the CD8 + T Cell Response During Primary Zika Virus Infection in Mice
|
journal
|
January 2017 |
|
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
|
journal
|
April 2016 |
|
Late sexual transmission of Zika virus related to persistence in the semen
|
journal
|
June 2016 |
|
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
|
journal
|
February 2018 |
|
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
|
journal
|
February 2018 |
|
Immune Response in Stat2 Knockout Mice
|
journal
|
December 2000 |
|
Zika virus and microcephaly: where do we go from here?
|
journal
|
March 2018 |
|
Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs
|
journal
|
October 2015 |
|
Induction of antigen-positive cell death by the expression of Perforin, but not DTa, from a DNA vaccine enhances the immune response
|
journal
|
December 2013 |
|
Vaccine protection against Zika virus from Brazil
|
journal
|
June 2016 |
|
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
|
journal
|
February 2017 |
|
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
|
journal
|
June 2016 |
|
A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
|
journal
|
April 2017 |
|
Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes
|
journal
|
June 2016 |
|
Extended surface for membrane association in Zika virus NS1 structure
|
journal
|
July 2016 |
|
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
|
journal
|
March 2018 |
|
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
|
journal
|
August 2018 |
|
Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein
|
journal
|
July 2018 |
|
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
|
journal
|
November 2017 |
|
Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses
|
journal
|
November 2016 |
|
Original antigenic sin in dengue revisited
|
journal
|
May 2013 |
|
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
|
journal
|
June 2016 |
|
Sequential Immunization with Heterologous Chimeric Flaviviruses Induces Broad‐Spectrum Cross‐Reactive CD8 + T Cell Responses
|
journal
|
July 2010 |
|
What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?
|
journal
|
December 2018 |
|
A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus
|
journal
|
September 2014 |
|
Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells
|
journal
|
July 2018 |
|
Maternal immunity and antibodies to dengue virus promote infection and Zika virus–induced microcephaly in fetuses
|
journal
|
February 2019 |
|
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
|
journal
|
July 2016 |
|
Zika vaccine trials
|
journal
|
September 2016 |
|
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
|
journal
|
December 2017 |
|
A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice
|
journal
|
May 2015 |
|
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans
|
journal
|
October 2017 |
|
Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice
|
journal
|
February 2018 |
|
Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent Mechanisms
|
journal
|
January 2006 |
|
Flavivirus NS1: a multifaceted enigmatic viral protein
|
journal
|
July 2016 |
|
Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates
|
journal
|
March 2012 |
|
Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1
|
journal
|
March 2014 |
|
Use of an In Vivo FTA Assay to Assess the Magnitude, Functional Avidity and Epitope Variant Cross-Reactivity of T Cell Responses Following HIV-1 Recombinant Poxvirus Vaccination
|
journal
|
August 2014 |
|
CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection
|
journal
|
September 2018 |
|
A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
|
journal
|
May 2019 |
|
Fluorescent target array killing assay: A multiplex cytotoxic T-cell assay to measure detailed T-cell antigen specificity and avidity in vivo
|
journal
|
June 2012 |
|
Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses
|
journal
|
March 2010 |
|
DNA vaccines encoding membrane-bound or secreted forms of heat shock protein 70 exhibit improved potency: Immunity to infection
|
journal
|
May 2014 |
Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection: Human T lymphocyte responses to DENV and ZIKV infections
- Badolato-Corrêa, Jessica; Sánchez-Arcila, Juan Camilo; Alves de Souza, Thiara Manuele
-
Immunity, Inflammation and Disease, Vol. 6, Issue 2
https://doi.org/10.1002/iid3.203
|
journal
|
December 2017 |
|
Immunolocalization of the Dengue Virus Nonstructural Glycoprotein NS1 Suggests a Role in Viral RNA Replication
|
journal
|
June 1996 |
|
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
|
journal
|
April 2016 |
|
Late sexual transmission of Zika virus related to persistence in the semen
|
journal
|
June 2016 |
|
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
|
journal
|
February 2018 |
|
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
|
journal
|
February 2018 |
|
Immune Response in Stat2 Knockout Mice
|
journal
|
December 2000 |
|
Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study
|
journal
|
March 2018 |
|
The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker
|
journal
|
May 2013 |
|
The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design
|
journal
|
June 2016 |
|
Modified mRNA Vaccines Protect against Zika Virus Infection
|
journal
|
March 2017 |
|
Modified mRNA Vaccines Protect against Zika Virus Infection
|
journal
|
March 2017 |
|
Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism
|
journal
|
February 2019 |
|
Mapping and Role of the CD8 + T Cell Response During Primary Zika Virus Infection in Mice
|
journal
|
January 2017 |
|
Zika Virus
|
journal
|
August 2016 |
|
Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells
|
journal
|
February 2019 |
|
Fluorescent target array T helper assay: A multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo
|
journal
|
January 2013 |
|
Dengue virus antibodies enhance Zika virus infection
|
journal
|
December 2016 |
|
Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs
|
journal
|
October 2015 |
|
Induction of antigen-positive cell death by the expression of Perforin, but not DTa, from a DNA vaccine enhances the immune response
|
journal
|
December 2013 |
|
Vaccine protection against Zika virus from Brazil
|
journal
|
June 2016 |
|
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
|
journal
|
February 2017 |
|
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
|
journal
|
June 2016 |
|
A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
|
journal
|
April 2017 |
|
Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes
|
journal
|
June 2016 |
|
Zika virus NS1 structure reveals diversity of electrostatic surfaces among flaviviruses
|
journal
|
April 2016 |
|
Extended surface for membrane association in Zika virus NS1 structure
|
journal
|
July 2016 |
|
A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses
|
journal
|
March 2018 |
|
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
|
journal
|
August 2018 |
|
Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model
|
journal
|
November 2018 |
|
Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein
|
journal
|
July 2018 |
|
Heterologous viral protein interactions within licensed seasonal influenza virus vaccines
|
journal
|
January 2020 |
|
A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model
|
journal
|
November 2017 |
|
Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology
|
journal
|
January 2016 |
|
A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice
|
journal
|
June 2016 |
|
Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses
|
journal
|
November 2016 |
|
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
|
journal
|
April 2013 |
|
Structural basis of Flavivirus NS1 assembly and antibody recognition
|
journal
|
March 2014 |
|
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
|
journal
|
June 2016 |
|
Sequential Immunization with Heterologous Chimeric Flaviviruses Induces Broad‐Spectrum Cross‐Reactive CD8 + T Cell Responses
|
journal
|
July 2010 |
|
Innate, T-, and B-Cell Responses in Acute Human Zika Patients
|
journal
|
August 2017 |
|
What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?
|
journal
|
December 2018 |
|
Zika Virus: What We Know and Do Not Know
|
journal
|
January 2016 |
|
A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus
|
journal
|
September 2014 |
|
Regulation of effector and memory T-cell functions by type I interferon: Type I interferon and adaptive T-cell functions
|
journal
|
February 2011 |
|
Flavivirus serocomplex cross-reactive immunity is protective by activating heterologous memory CD4 T cells
|
journal
|
July 2018 |
|
Maternal immunity and antibodies to dengue virus promote infection and Zika virus–induced microcephaly in fetuses
|
journal
|
February 2019 |
|
Flavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune System
|
journal
|
February 2014 |
|
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
|
journal
|
July 2016 |
|
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
|
journal
|
August 2016 |
|
Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
|
journal
|
September 2015 |
|
Durability and correlates of vaccine protection against Zika virus in rhesus monkeys
|
journal
|
December 2017 |
|
A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice
|
journal
|
May 2015 |
|
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans
|
journal
|
October 2017 |
|
Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice
|
journal
|
February 2018 |
|
Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc Receptor-Dependent and -Independent Mechanisms
|
journal
|
January 2006 |
|
Flavivirus NS1: a multifaceted enigmatic viral protein
|
journal
|
July 2016 |
|
Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates
|
journal
|
March 2012 |
|
Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1
|
journal
|
March 2014 |
|
Use of an In Vivo FTA Assay to Assess the Magnitude, Functional Avidity and Epitope Variant Cross-Reactivity of T Cell Responses Following HIV-1 Recombinant Poxvirus Vaccination
|
journal
|
August 2014 |
|
CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection
|
journal
|
September 2018 |
|
CD4+ T cells promote humoral immunity and viral control during Zika virus infection
|
journal
|
January 2019 |
|
Zika virus NS 1, a pathogenicity factor with many faces
|
journal
|
October 2016 |
|
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans
|
text
|
January 2017 |
|
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
|
text
|
January 2013 |
|
Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood
|
journal
|
January 2017 |
|
A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice
|
journal
|
May 2019 |
|
Protection from Secondary Dengue Virus Infection in a Mouse Model Reveals the Role of Serotype Cross-Reactive B and T Cells
|
journal
|
November 2011 |
|
STAT2 Is Required for TLR-Induced Murine Dendritic Cell Activation and Cross-Presentation
|
journal
|
May 2016 |
|
Regulation of IFN-γ Signaling Is Essential for the Cytotoxic Activity of CD8 + T Cells
|
journal
|
November 2001 |
|
Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency
|
journal
|
September 2014 |